Bio-Techne Corporation (T1CH34.SA)
| Previous close | 14.20 |
| Open | 0.00 |
| Bid | 13.64 x N/A |
| Ask | 13.73 x N/A |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 114 |
| Market cap | 67.131B |
| Beta (5Y monthly) | 1.23 |
| PE ratio (TTM) | 64.55 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.04 (0.27%) |
| Ex-dividend date | 10 May 2024 |
| 1y target est | N/A |
- Insider Monkey
Multiple Headwinds Dragged Bio-Techne Corp. (TECH) in Q1
Conestoga Capital Advisors, an asset management company, released its “Mid-Cap Strategy” first-quarter 2024 investor letter. A copy of the letter can be downloaded here. It was a solid quarter as many asset classes moved higher. The S&P Index, which tracks the performance of large-cap stocks, reached an all-time high on March 28th, and the Russell 2000 […]
- Insider Monkey
Bio-Techne Corporation (TECH) Declined on Weak Q4 Results
Baron Funds, an investment management company, released its “Baron Asset Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here. US markets continued its strong rally in the first quarter. Robust economic data and relatively strong corporate earnings boosted the rally along with the anticipation of a soft landing of […]
- Simply Wall St.
Bio-Techne Third Quarter 2024 Earnings: Beats Expectations
Bio-Techne ( NASDAQ:TECH ) Third Quarter 2024 Results Key Financial Results Revenue: US$303.4m (up 3.2% from 3Q 2023...
